Healthcare
Peptomyc raises €1m round from Riva y García
Business angels and institutional investors also participated in the funding round
Aksìa Group buys medical packaging maker Lameplast
Deal sees the founders and previous owners fully exit the pharma packaging business
Gemmes reaps €12m in Asten partial exit
Gemmes Venture will remain the majority shareholder in the business
Principia invests €7m in Silk Biomaterials
Deal marks the third transaction of the biomedical- and healthcare-focused Principia III fund
NorthEdge acquires mattress maker DHS
Management buyout marks the GP's maiden investment in the healthcare market
Nestlé Health Science joins €14.5m Enterome series-C
Funds will help Enterome push research into gut bacteria-related diseases
Gimv et al. lead €36m series-A for G-Therapeutics
Listed buyout house Gimv invested €6m in the funding round led by LSP and Inkef
Seventure leads €5.8m series-A for appetite researcher TargeDys
Funds will help bring the company's 10-year research project to fruition
Forbion closes third fund on $208m
The VC has bolstered its Munich-based team hiring Matthias Falcenberg as an analyst
Capricorn et al. back €10m series-B for iStar
The funding will help iStar finalise the development of its current product MINIject
Enterprise Investors sells 17.3% of PBKM ahead of Warsaw IPO
Trading of shares in the Polish stem-cell bank will begin on April 28 on the Warsaw stock exchange
Investindustrial acquires Artsana
Investindustrial VI completes first transaction after final close on €2bn hard-cap
Maven backs £12m MBO of Westfield Medical
Sterilisation packaging company will look to increase production and international sales
Gilde leads €25m series-C for Stat-Diagnostica
Backers include Kurma Partners, Ysios Capital, Idinvest Partners, Caixa Capital Risc and others
Scottish Enterprise et al. in £27.5m Touch Bionics trade sale
Deal comes five years after a £2.5m investment in the Scottish prosthetics company
Dunedin promotes Hoare and Rowan to partner
Davidson and Chung are also promoted following an active first quarter for the UK firm
EdRip leads €34m series-B for MedDay
French biotech is to begin the third US testing phase for its multiple sclerosis drug
HTGF backs Thermosome’s €4.6m round
Biotech startup Thermosome raises €4.6m from investors and the German governement
Catapult exits FDAS
Catapult first backed the quality control testing company when it was created in 2004
Bluebee raises €10m series-A from Capricorn et al.
Backers include family office Kory and Biover II
HTGF backs Amal Therapeutics’ CHF 3m series-A
Round also saw participation from Boehringer Ingelheim Venture Fund and VI Partners
Deal in Focus: Adelis in DKK 250m buyout of SSI Diagnostica
Swedish GP Adelis completes the DKK 250m privatisation of Danish niche pharma company SSI Diagnostica
Baxalta and Medicxi lead €7m series-A for Gadeta
Backers include Utrecht Holdings, founders and the management team
Iterum Therapeutics raises $40m
Newly created company has also been granted global licensing rights for a new antibiotic